The isoflavone genistein is found predominantly in soyabeans and is thought to possess various potent biological properties, including anticarcinogenic effects. Studies have shown that genistein is extensively degraded by the human gut microflora, presumably with a loss of its anti-carcinogenic action. The aim of the present study was to investigate the potential of a prebiotic to divert bacterial metabolism away from genistein breakdown: this may be of benefit to the host. Faecal samples were obtained from healthy volunteers and fermented in the presence of a source of soyabean isoflavones (Novasoye (10 g/l); ADM Neutraceuticals, Erith, Kent, UK). Bacterial genera of the human gut were enumerated using selective agars and genistein was quantified by HPLC. The experiment was repeated with the addition of glucose (10 g/l) or fructo-oligosaccharide (10 g/l; FOS) to the fermentation medium. The results showed most notably that counts of Bifidobacterium spp. and Lactobacillus spp. were significantly increased (P,0·05 and P,0·01 respectively) under steady-state conditions in the presence of FOS. Counts of Bacteroides spp. and Clostridium spp. were, however, both significantly reduced (P, 0·05) during the fermentation. A decline in genistein concentration by about 52 and 56 % over the 120 h culture period was observed with the addition of glucose or FOS to the basal medium (P, 0·01), compared with about 91 % loss of genistein in the vessels containing Novasoye (ADM Neutraceuticals) only. Similar trends were obtained using a three-stage chemostat (gut model), in which once again the degradation of genistein was about 22 % in vessel one, about 24 % in vessel two and about 26 % in vessel three in the presence of FOS, compared with a degradation of genistein of about 67 % in vessel one, about 95 % in vessel two and about 93 % in vessel three in the gut model containing Novasoye (ADM Neutraceuticals) only. The present study has shown that the addition of excess substrate appeared to preserve genistein in vitro. In particular, the use of FOS not only augmented this effect, but also conferred an additional benefit in selectively increasing numbers of purportedly beneficial bacteria such as bifidobacteria and lactobacilli.
The isoflavone genistein belongs to a class of hormone-like diphenolic phyto-oestrogens and it possesses a similar structure to the female oestrogen, oestradiol 17b (Adlercreutz, 1995; Cassidy, 1999) . Scientific interest in soyabean isoflavones, and in particular genistein, has increased dramatically over the past few years. Initially, this interest stemmed from epidemiological observations that the incidence of hormone-related diseases, and some cancers in particular, were much lower in Japan and China where soyabeans are commonly consumed in the diet (Setchell, 1998) .
Genistein is predominantly present in plants and therefore in the diet as the glycoside, genistin (Murphy et al. 1997) . Following ingestion, it is hydrolysed to the aglycone, genistein, by b-glucosidases. Enzymes capable of carrying out this deglycosylation step are found at the small intestinal brush border (lactase phloridzin hydrolase; Day et al. 2000) and within enterocytes (cytosolic b-glucosidases; Day et al. 1998) . In addition, several major groups of colonic bacteria possess b-glucosidase activity, including Lactobacillus spp., Bacteroides spp. and Bifidobacterium spp. (Hawksworth et al. 1971; Friend & Chang, 1984) .
Pharmacokinetic studies confirm that healthy adults absorb genistein rapidly and efficiently. In most adults, peak plasma concentrations of genistein following ingestion of the aglycone are between 4 and 7 h, whereas following consumption of the b-glucoside, the plasma concentration peaks at about 8 -11 h. The latter result suggests that bioavailability of genistin is dependent upon deglycosylation by intestinal bacteria (Setchell et al. 2001) . Excretion of the aglycone occurs mainly in urine and to some extent in faeces; however, in a feeding study with human subjects, where the subjects were given known doses of genistein ranging from 3·4 to 10·3 mmol/kg body weight, an incomplete recovery of intact genistein ranging from 14 to 43 % seems to suggest that isoflavone aglycones are extensively degraded, probably by human intestinal bacteria (Xu & Thomas, 1995) .
Genistein undergoes a reduction of the C-ring at C 2 and C 3 to form an intermediary molecule dihydrogenistein. At this point, the metabolism may proceed in two different ways: cleavage of the C-ring at C 3 and C 4 to produce 6 0 -hydroxy-O-desmethylagolensin or complete cleavage of the C-ring to produce 2,4,6-trihydroxybenzoic acid and p-ethyl phenol, with both these endproducts being metabolically inactive. Both Kim et al. (1998) and Chang & Nair (1995) have demonstrated the conversion of genistein to dihydrogenistein by human faecal bacteria, but neither study identified the microbial genera involved. Hur et al. (2000) isolated E. coli and an unidentified Gram-positive strain capable of degrading genistein, whilst Schoefer et al. (2002) demonstrated that Eubacterium ramulus isolated from human faeces was also capable of degrading genistein.
De Boever et al. (2000) used a colonic model to investigate the prebiotic effect of soyagerm powder. They reported an overall increase in all bacterial groups compared with controls, with a log 10 2 increase in Lactobacillus spp. However, several major bacterial groups were isolated, including Bacteroides spp. and Bifidobacterium spp., and only the breakdown of the glycoside to the aglycone genistein was investigated.
The aim of the present study was to use anaerobic fermentation techniques and HPLC analyses to confirm that human gut bacteria are capable of breaking down the aglycone isoflavone genistein and to investigate the potential of a prebiotic to reduce this function.
Materials and methods

Single-stage continuous cultures
Continuous cultures to study the bacterial metabolism of genistein in the presence and absence of excess substrate were prepared as follows. Basal medium (150 ml; containing (per litre): peptone water 2 g, yeast extract 2 g, NaCl 0·10 g, K 2 HPO 4 0·04 g, KH 2 PO 4 0·04 g, Mg 2 SO 4 .7H 2 O 0·01 g, CaCl 2 .2H 2 O 0·01 g, Tween 80 2 ml, hemin 0·005 g, phylloquinone 10 ml (10 mg/ml), cysteine-HCl 0·50 g, bile salts 0·50 g, resazurin 0·001 g) was placed in each of three separate reaction vessels (working volume 300 ml) and sparged with N 2 gas (15 ml/min). The temperature of the growth medium was maintained at 378C and the culture pH was maintained at 6·5 through automatic addition of 1 M-NaOH or 1 M-HCl.
Faecal samples were obtained from three healthy volunteers (one male, two female; average age 32·7 (SD 10·9) years). None of the volunteers had been prescribed antibiotics for at least 3 months prior to donating samples or had any history of gastrointestinal disorders. The reaction vessels were inoculated with faecal slurry (100 g/l) prepared in anaerobic 0·1 M-phosphate buffer, pH 7·0, to give a final concentration of 50 g/l in the culture vessel. After inoculation, chemostats were left for 24 h to equilibrate before the medium pump was switched on. Sterile medium was added from a 5 litre reservoir vessel using a Watson-Marlow pump (Watson Marlow, Falmouth, UK) to regulate the flow rate. The dilution rate was set at 0·03 litres/h.
Reservoir vessels contained either basal medium with Novasoye (200 g genistin/kg, 10 g Novasoye/l; ADM Nutraceuticals, Erith, Kent, UK) or the same medium containing either 10 g glucose or 10 g fructo-oligosaccharide (FOS)/l. Samples (1 ml) were removed from each reaction vessel at 0 h (t 0), 24 h and at steady state (approximately seven culture turnovers). Under anaerobic conditions (CO 2 -H 2 -N 2 (10:10:80, by vol.)), tenfold serial dilutions (from 10 1 and 10 7 ) were prepared using sterile, pre-reduced half-strength peptone water (9 ml); portions, placed into glass bottles, contained (per litre): peptone 1 g, cysteineHCl 0·5 g, adjusted to pH 7·0 using 4 M-NaOH. A 20 ml sample was taken from each dilution series and plated in triplicate onto selective agars for the enumeration of predominant genera of gut bacteria. Eight purportedly selective agars were used for quantification (Table 1 ). In addition, duplicate samples (250 ml) were taken at 0, 6 and every 24 h thereafter for HPLC analysis of genistin and genistein. Samples were mixed with 250 ml methanol and 500 ml dimethyl sulfoxide, vortexed and stored at 2 208C for analysis by HPLC. The experiment was repeated in triplicate using a faecal sample from a different subject each time.
Three-stage continuous culture (gut model)
A three-stage continuous culture system, representing conditions present in the proximal, transverse and descending colon, was used to evaluate the fermentation of genistein in the human large intestine. The system comprised a pumped cascade of three reaction vessels (working volumes 280, 300 and 300 ml). Culture pH in the three fermentation vessels was automatically adjusted to 5·5, 6·2 and 7·0 Table 1 . Selective agars and their modifications as used for determining counts of major genera resident in the human large intestine Agar* Selectivity for genera Additions to agar
Wilkins-Chalgren agar Total anaerobes -Columbia agar Bifidobacterium spp. Glucose and agar (5 g/l), cysteine-HCl (0·5 g/l), propionic acid (5 ml/l). Adjusted to pH 5·0 using 4 M-NaOH Brucella blood-base agar Bacteroides spp. Hemin (5 mg/ml), phylloquinone (10 mg/ml), kanamycin (75 mg/ml), vancomycin (7·5 mg/ml), laked horse blood (50 ml/l) Rogosa agar Lactobacillus spp. Glacial acetic acid (1·32 ml/l) Reinforced Clostridial agar Clostridium spp. Novobiocin (8 mg/l), cholistin (8 mg/l) Azide agar
Gram-positive cocci -Nutrient agar Total aerobes -MacConkey agar Coliforms -* All agars used were purchased from Oxoid (Basingstoke, Hants., UK) and prepared according to the supplier's instructions.
respectively through the automatic addition of 1 M-NaOH or 1 M-HCl as appropriate. Each vessel was magnetically stirred and sparged with N 2 gas (15 ml/min) to maintain anaerobic conditions. The temperature of each vessel was maintained at 378C using a circulating water-bath. The reaction vessels were inoculated with faecal slurry (100 g/l, 0·1 M-phosphate buffer, pH 7·0) to give a final concentration of 50 g/l. After inoculation, 1 ml faecal slurry was taken for the enumeration of bacteria as described earlier. The three-vessel system was left for 24 h to equilibrate before the medium pump was switched on. Sterile basal medium containing Novasoye (10 g/l; ADM Neutraceuticals) was added from a 5 litre reservoir vessel using a Watson-Marlow pump to regulate flow rate. The system had an overall retention time of 70 h. After steady-state conditions had been established (at least seven culture turnovers, about 490 h), samples (1 ml) were taken from the three reaction vessels for the enumeration of bacteria as described earlier. In addition, duplicate samples (250 ml) were taken from each vessel for HPLCbased analysis of genistin and genistein. The gut model experiment was repeated as described earlier, but with the addition of FOS (10 g/l) in the basal medium to study the metabolism of genistein by human intestinal bacteria in the presence of a prebiotic. Samples were taken as described earlier for the enumeration of major intestinal bacterial genera on selective agars and for analysis of genistin and genistein by HPLC.
HPLC analysis of isoflavones
Samples from the fermentation experiments were analysed for genistin and genistein by HPLC using a method adapted from that of Wang & Murphy (1994) . A Waters 600E system controller and pump coupled to a Waters 484 u.v. detector was used (Waters Ltd, Elstree, UK ). The column (5 mm, 250·0 £ 4·6 mm) was packed with Prodigy 5 mm optical density spheres (3) 100A (Phenomenex, Macclesfield, Ches., UK). Solvents A (1 ml glacial acetic acid/l HPLC water) and B (undiluted acetonitrile) were run using a linear gradient of 15 % B (6 min), increasing to 29 % B (30 min), 35 % B (8 min), 50 % B (5 min) and then to 90 % B (4 min). Both solvents A and B were continually gassed with He. The flow rate was 1·0 ml/min for the first 5 min; this was increased to 1·5 ml/min over 1 min, maintained for 50 min at 1·5 ml/min then returned to 1·0 ml/min for the remaining 15 min of the total run time. Each sample was spiked with an internal standard (2 mmol quercetin/l) to check for recovery and injected (20 ml) onto the column. The eluate was monitored for absorbance at 260 nm. U.v. spectra and peak areas were integrated using a Hewlett Packard 3396A integrator (Hewlett Packard, Bracknell, UK). Calibration curves for genistin and genistein (2 mmol to 125 mmol/l) were prepared, and the content of samples expressed as mmol/l fermentation medium.
Statistical analysis
Bacterial counts from single-stage chemostats were analysed using a two-tailed paired t test for differences between initial counts and steady-state counts and differences between each treatment. Bacterial counts from the gut model were not analysed statistically as this experiment was carried out using only one subject.
Results
Single-stage continuous cultures with Novasoye
Bacterial counts of major genera of human faecal bacteria, initially and at steady state, in single-stage continuous cultures using media without and with glucose or FOS, are shown in Fig. 1 . Counts represent data from three separate experiments using faecal samples from three separate individuals with the standard deviation representing the variation between the experiments. Counts of total anaerobic bacteria significantly increased (P, 0·05) at steady state in the presence of FOS (10 g/l). Numbers of Bifidobacterium spp. and Lactobacillus spp. were also significantly higher (P, 0·05 and P, 0·01 respectively) at steady state in the presence of FOS. However, Bacteroides spp. and Clostridium spp. both showed a statistically significant (P, 0·05) decrease in counts under all substrate conditions tested when compared with initial counts.
HPLC analysis of isoflavones from continuous cultures
Baseline analyses of each batch of basal medium with Novasoye (10 g/l; ADM Neutraceuticals) showed that initial levels of genistin and genistein were 7480 (SD 250) and 145 (SD 29) mmol/l respectively. Fig. 2 shows the metabolism of genistin and genistein by human faecal bacteria in pH-controlled (6·5) continuous culture in the presence of basal medium containing Novasoye (10 g/l; ADM Neutraceuticals). Genistin was rapidly metabolised within the first 5 h of fermentation and was reduced to undetectable levels for the remainder of the experiment, suggesting efficient deglycosylation. Correspondingly, genistein increased rapidly during the first 5 h of fermentation, reaching a peak level of 1875 (SD 131) mmol/l 55 h after initial inoculation and decreased thereafter to 652 (SD 72) mmol/l 125 h after inoculation. Fig. 3 shows the metabolism of genistin and genistein by human faecal bacteria in pH-controlled (6·5) continuous culture in the presence of basal medium containing Novasoye (10 g/l; ADM Neutraceuticals) and glucose (10 g/l). As in the unsupplemented medium, genistin decreased to undetectable levels within the first 5 h after inoculation, with a corresponding increase in genistein. A peak level of 3592 (SD 90) mmol/l was reached 100 h after inoculation. Genistein formation was significantly higher (P, 0·01) at all time points under these culture conditions when compared with the unsupplemented controls.
When human faecal bacteria were incubated under these conditions using media supplemented with FOS (10 g/l; Fig. 4) , genistin again decreased to undetectable levels within the first 5 h. Genistein concentrations were similar to those seen with the glucose-supplemented media, and were significantly higher than those from the unsupplemented control.
Three-stage continuous culture (gut model) using Novasoye
Counts of human faecal bacteria in a pH-controlled threestage continuous culture system with basal medium containing Novasoye (10 g/l; ADM Neutraceuticals) are shown in Fig. 5 . No increase in bacterial numbers was observed in any of the three vessels compared with initial counts. In vessel one, Bacteroides spp. and Clostridium spp. decreased by 5·51 and 4·93 log counts respectively. In vessel two, counts of Clostridium spp. remained low at 5·68 (SD 0·61) log counts, whilst total anaerobes and coliforms were detected at 5·80 (SD 0·03) and 5·21 (SD 0·03) log counts respectively. In vessel three, Lactobacillus spp. showed the greatest decrease of 3·50 log counts, whilst counts of Clostridium spp. recovered to 7·90 (SD 0·08). When the experiment was repeated using media supplemented with FOS (Fig. 6) , the only genus to increase in counts in vessel one was Lactobacillus spp. (0·26 log counts). Bacteroides spp., Clostridium spp., total anaerobes and coliforms all decreased below the level of detection. Both Bacteroides spp. and Clostridium spp. recovered their counts in vessel two and vessel three, but did not increase to levels observed initially. Fig. 7 shows the metabolism of genistin and genistein by human faecal bacteria in a three-stage continuous culture using basal (unsupplemented) media. In all three vessels, genistin was deglycosylated to form genistein within the first 24 h of fermentation. Genistein levels in vessels one, two and three increased over the first 48 h of fermentation to 2470 (SD 110), 2522 (SD 189) and 2568 (SD 41) mmol/l respectively. In contrast to vessel one, where genistein levels remained constant between 48 and 140 h after inoculation, in vessel two they had declined to 374 (SD 29) mmol/l and in vessel three to 511 (SD 89) mmol/l. Fig. 8 shows the metabolism of genistin and genistein by human faecal bacteria in a three-stage continuous culture in the presence of FOS (10 g/l). Similar to the previous gut model experiments, conjugated forms of genistein disappeared to negligible levels within the first 24 h of fermentation in all three vessels. In vessel one, genistein maintained a much higher level during the fermentation period compared with those levels seen previously in vessel one. Genistein increased during the fermentation period to reach a maximum level of 6130 (SD 201) mmol/l 125 h after inoculation. A similar level of genistein was also observed in vessel two and vessel three, where genistein increased to 5656 (SD 43) and 5510 (SD 79) mmol/l 225 h after inoculation respectively and remained relatively stable.
HPLC analysis of isoflavones from the gut model
Discussion
The aim of the present study was to determine the effect of prebiotics to preserve genistein in the presence of human faecal bacteria in order to maintain its purported health benefits. Novasoye (ADM Neutraceuticals) was used as a source of genistein in the fermentation experiments. It contained a complex mix of conjugated isoflavones (200 g genistin, 154 g daidzein and 40 g glycitin/kg), other unspecified phyto-components (400 g/kg), protein (120 g/kg) and fat (70 g/kg). Whilst the use of this substrate complicated bacterial analysis, the cost of pure genistein precluded use in such experiments.
A generally consistent pattern of bacterial counts was observed in all the fermentation experiments carried out. Populations of Bifidobacterium spp. and Lactobacillus spp. were maintained in single-stage chemostats and in the first vessel of the gut model system, whilst Bacteroides spp. and Clostridium spp. decreased. In fermentation experiments where FOS was used, an increase in Bifidobacterium spp. and Lactobacillus spp. was observed, although this was only significant in the single-stage chemostat. Such an increase was expected, since it has been well documented that FOS is selectively metabolised by such genera (Williams et al. 1994; Gibson et al. 1995; Buddington et al. 1996) .
The rapid metabolism of genistin over the first 24 h in all fermentation experiments was not surprising. Several major groups of intestinal bacteria possess b-glucosidase activity, including Lactobacillus spp., Bacteroides spp. and Bifidobacterium spp. (Hawksworth et al. 1971; Friend & Chang, 1984) . Glucose liberation during deglucosylation would also have enriched the medium for bacterial growth. In all cases, a decrease in the concentration of the glycoside (genistin) was accompanied by a concomitant rapid rise in aglycone (genistein) levels. In the singlestage continuous cultures using a basal medium, genistein concentrations then declined slowly. A similar profile was observed in the first vessel of the gut model chemostats, except that genistein was maintained at a slightly higher level. These results suggest two possible scenarios: either strains unable to metabolise this compound were washed out of the system whilst strains able to metabolise genistein were enriched, or the balance between genistin deglycosylation by certain genera was slightly outweighed by degradation by the same or perhaps by other genera. In contrast, however, the genistein profiles of vessels two and three in the gut model were very different and genistein concentrations in the culture medium were rapidly reduced to reach very low levels. Initially, this may suggest that the breakdown of genistein was favoured by a higher pH. However, this is not entirely consistent with the observation that genistein levels were maintained in the single-stage chemostats at pH 6·5, and that bacterial ecology suggests that the metabolism of genistein was predominated by bacterial genera that tended to survive at a lower pH. The consistently high levels of genistein maintained in single-stage chemostats, and in vessel one of the more complex gut model, were indicative of an equilibrium being reached between the supply of isoflavonoid, deglycosylation and further metabolism.
FOS was incorporated into the growth medium for continuous cultures to assess whether isoflavone breakdown might be reduced in an environment where Bifidobacterium spp. and Lactobacillus spp. counts were elevated. Incorporation of either glucose or FOS into the basal medium significantly increased the level by which genistein was maintained in the single-and multi-stage continuous cultures, indicative of a preserving function of both glucose and FOS. There was no significant difference between the two substrates with regard to this effect. However, Xu & Thomas (1995) have suggested that due to its structure, genistein is more vulnerable to degradation than other isoflavones such as daidzein. This is supported by the observations of Griffiths & Smith (1972) who, using a rat model, demonstrated that isoflavones possessing a 5-OH group (such as genistein but not daidzein) were much more susceptible to C-ring cleavage.
Furthermore the preservation of genistein in the presence of FOS was seen in all three vessels. In vessel one, peak levels were reached 125 h after inoculation, whilst peak levels in vessels two and three were attained 225 h after inoculation. This suggests that these levels in vessels two and three were dependent upon the supply of medium from vessel one. Indeed, this would fit with the turnover time of 70 h and would indicate that FOS was not completely utilised in vessel one, but persisted through to vessels two and three, maintaining counts of Bifidobacterium spp. and Lactobacillus spp. in these vessels, whilst at the same time diverting metabolism away from genistein degradation. It might be reasonable to assume some persistence of FOS through the gut model, since several trials with human subjects (Hidaka et al. 1986; Mitsuoka et al. 1987; Gibson et al. 1995; Buddington et al. 1996) have shown an increase in faecal Bifidobacterium spp. when the prebiotic has been fed to human volunteers.
It is acknowledged that in the fermentation experiments carried out here, Novasoye (ADM Neutraceuticals) was present in excess, the bacterial exposure levels being approximately fourteen times the reported daily total isoflavone intake where soyabean products are regularly consumed in the diet (Cassidy, 1999) . This could have created a stressed environment (Rumney & Rowland, 1992) and extrapolation of the results to the in vivo situation should be carried out with caution. However, the results suggest that Bifidobacterium spp. and Lactobacillus spp. may be very effective deglycosylators, whereas Bacteroides spp. and Clostridium spp may play a role in degrading the aglycone further. The addition of excess substrate appeared to preserve genistein in vitro. In particular, the use of FOS as a substrate not only preserved genistein to a greater extent, but also conferred an extra benefit through a selective increase of beneficial bacterial genera such as Bifidobacterium spp. and Lactobacillus spp.
